Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 421
Filter
1.
PLoS One ; 18(3): e0280885, 2023.
Article in English | MEDLINE | ID: mdl-36893178

ABSTRACT

An innovative approach, Raman microspectroscopy coupled with deuterium isotope probing (Raman-DIP), can be used to evaluate the metabolism of deuterated carbon source in bacteria and also to presume different anabolic pathways. This method requires the treatment of cells with heavy water that could affect the bacterial viability state at higher concentration. In this study, we evaluated the effect of heavy water incorporation on the viability state of Listeria innocua cells. We exposed the L. innocua suspensions to different heavy water concentrations (0%, 25%, 50% and 75%) from 30 minutes to 72 h of incubation times at 37°C. The total, viable and viable culturable populations were quantified by qPCR, PMA-qPCR and plate count agar respectively. We analyzed heavy water incorporation by Raman-DIP. The exposure of L. innocua cells to different concentrations of heavy water did not alter their cell viability to 24 h incubation time. In addition, the maximum intensity for C-D band, specific for the incorporation of heavy water, was reached after 2 h of exposure in a media containing 75% v/v D2O but an early detection of the labelling was possible at t = 1 h 30 min. In conclusion, the use of D2O as a metabolic marker was validated and can be developed for the detection of L. innocua cell viability state.


Subject(s)
Listeria , Deuterium/pharmacology , Deuterium Oxide , Microbial Viability
2.
Anticancer Drugs ; 34(10): 1162-1170, 2023 11 01.
Article in English | MEDLINE | ID: mdl-36847076

ABSTRACT

Colorectal cancer is one of the most common types of cancer in the world and the study of the role of nutrients in preventing or inhibiting the growth of this cancer is of interest to scientists. In this article, the synergistic effect of deuterium-depleted water(DDW) and crocin at specific concentrations on HT-29 cells was investigated. In this regard, HT-29 cells were grown in RPMI medium containing DDW, alone and in combination with crocin for 24, 48 and 72 h. Cell viability, cell cycle changes and antioxidant enzymes status were determined by MTT assay, flow cytometry and quantitative luminescence methods, respectively. The results of these analyses proved the cell growth inhibitory effect of deuterium alone and its synergistic effect in combination with crocin. The cell cycle analysis showed an increase in the number of cells in the G0 and G1 phases whereas there was a decrease in the number of cells in the S, G2 and M phases. The activities of superoxide dismutase and catalase enzymes also decreased compared to the control group that is a reason to increase Malonyl dialdehyde factor. The results suggested that a combination of DDW and crocin can open a new strategic approach in the prevention and treatment of colorectal cancer.


Subject(s)
Colorectal Neoplasms , Water , Humans , Deuterium/metabolism , Deuterium/pharmacology , HT29 Cells , Water/pharmacology , Colorectal Neoplasms/drug therapy
3.
Pathol Res Pract ; 240: 154186, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36327814

ABSTRACT

The aim of current work was able to show the oxidant effect of cancer cells found in any part of the body on the liver and to investigate the possible protective effect of deuterium-depleted water (DDW) on this oxidant effect by determining of some liver parameters. Ehrlich ascites tumor bearing BALB/c mice were used for this purpose. BALB/c mice were selected randomly and divided into four groups (n = 5 in each group) as control group, tumor group, control+DDW group, tumor+DDW group, fifteen days after tumor cell injection, liver tissue samples were taken for all groups. In the tumor group, liver lipid peroxidation, sialic acid and protein carbonyl levels, xanthine oxidase, myeloperoxidase, catalase, gamma-glutamyl transferase, sorbitol dehydrogenase, glutathione peroxidase and glutathione reductase activities, were significantly higher than those in the control group while glutathione levels and paraoxonase1, sodium potassium ATPase, glutathione-S-transferase, alanine transaminase and aspartate transaminase activities decreased significantly. Compared with the tumor group, the changes in all parameters except sialic acid, catalase, alanine transaminase and aspartate transaminase were reversed in the DDW given tumor groups, while sialic acid and catalase values continued to increase, and alanine transaminase and aspartate transaminase values continued to decrease. In conclusion, the consumption of DDW may be beneficial and protective against excessive oxidative stress in cancer complications.


Subject(s)
Drinking Water , Mice , Animals , Catalase/metabolism , Alanine Transaminase/metabolism , Alanine Transaminase/pharmacology , Drinking Water/metabolism , Deuterium/metabolism , Deuterium/pharmacology , N-Acetylneuraminic Acid/metabolism , N-Acetylneuraminic Acid/pharmacology , Oxidative Stress , Aspartate Aminotransferases/metabolism , Aspartate Aminotransferases/pharmacology , Lipid Peroxidation , Antioxidants/pharmacology , Glutathione/metabolism , Liver/pathology , Glutathione Transferase , Oxidants/metabolism , Oxidants/pharmacology , Superoxide Dismutase/metabolism
5.
Eur J Pharm Sci ; 172: 106157, 2022 May 01.
Article in English | MEDLINE | ID: mdl-35257876

ABSTRACT

BACKGROUND AND PURPOSE: Despite being a first-line clinical drug, thienopyridines have many unsatisfactory aspects, including the low bioavailability of clopidogrel(CLP) and the high bleeding risk of prasugrel. We synthesized deuterium clopidogrel(D-CL, patented in China) to alleviate the deficiency of CLP in clinical, such as a slow onset, a greater influence of gene polymorphism, and a high frequency of drug-drug interaction. EXPERIMENTAL APPROACH: Molecular docking was used to analyze the affinity between D-CL and the P2Y12 receptor. The levels of active metabolites of D-CL were detected using HPLC/MS-MS and the activities of main metabolic enzymes were analyzed; Subsequently, platelet aggregation function, thrombus model were used to evaluate the pharmacodynamics of D-CL. Finally, the safety of D-CL were evaluated through examination of blood routine, PT, APTT, bleeding time, serological tests, liver pathological biopsy, liver cell apoptosis and detection of apoptosis-related proteins. KEY RESULTS: The introduction of deuterium made the binding of CLP to P2Y12 receptor more stable, improved the concentration of active metabolites, and substantially reduced the inhibition of major metabolic enzymes, including CYP2B6, CYP2C9, and CYP2C19, thereby, exerting better antiplatelet effects without increasing the risk of bleeding, along with a concomitant decrease in the apoptosis of hepatocytes.


Subject(s)
Hydrogen , Platelet Aggregation Inhibitors , Clopidogrel/pharmacology , Deuterium/pharmacology , Formic Acid Esters , Hydrogen/pharmacology , Molecular Docking Simulation , Platelet Aggregation , Platelet Aggregation Inhibitors/pharmacology , Thiophenes/pharmacology
6.
Bull Exp Biol Med ; 171(5): 572-575, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34617175

ABSTRACT

The role of stable hydrogen isotopes in the thermoregulation and its regulation is poorly studied. We analyzed fluctuations in body temperature and changes in thermoregulation parameters in mice under conditions of reduced deuterium intake. The study was performed on male C57BL/6 mice that consumed water with a low (10 ppm) and normal (146 ppm) deuterium content. In 7 days, fluctuations of body temperature, locomotor activity, and oxygen uptake were assessed. Deuterium depletion in the body reduced the mean value of minute fluctuations of body temperature and the mean spectral density of minute fluctuations in body temperature in the 2-20-min periods. This attested to a stabilizing effect of deuterium depletion on the rhythms of body temperature fluctuations, without significant shifts in the thermogenesis parameters. Thus, drinking water with reduced deuterium content makes them less sensitive to external influences.


Subject(s)
Body Temperature Regulation , Deuterium/pharmacokinetics , Drinking Behavior/physiology , Animals , Body Temperature/drug effects , Body Temperature/physiology , Body Temperature Regulation/drug effects , Body Temperature Regulation/physiology , Deuterium/analysis , Deuterium/pharmacology , Drinking Behavior/drug effects , Locomotion/drug effects , Locomotion/physiology , Male , Mice , Mice, Inbred C57BL , Thermogenesis/drug effects , Thermogenesis/physiology , Water/chemistry , Water/metabolism , Water/pharmacology
7.
Emerg Microbes Infect ; 10(1): 1832-1848, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34427541

ABSTRACT

Seasonal influenza A virus (IAV) infections are among the most important global health problems. FDA-approved antiviral therapies against IAV include neuraminidase inhibitors, M2 inhibitors, and polymerase inhibitor baloxavir. Resistance against adamantanes (amantadine and rimantadine) is widespread as virtually all IAV strains currently circulating in the human population are resistant to adamantanes through the acquisition of the S31N mutation. The neuraminidase inhibitor-resistant strains also contain the M2-S31N mutant, suggesting M2-S31N is a high-profile antiviral drug target. Here we report the development of a novel deuterium-containing M2-S31N inhibitor UAWJ280. UAWJ280 had broad-spectrum antiviral activity against both oseltamivir sensitive and -resistant influenza A strains and had a synergistic antiviral effect in combination with oseltamivir in cell culture. In vivo pharmacokinetic (PK) studies demonstrated that UAWJ280 had favourable PK properties. The in vivo mouse model study showed that UAWJ280 was effective alone or in combination with oseltamivir in improving clinical signs and survival after lethal challenge with an oseltamivir sensitive IAV H1N1 strain. Furthermore, UAWJ280 was also able to ameliorate clinical signs and increase survival when mice were challenged with an oseltamivir-resistant IAV H1N1 strain. In conclusion, we show for the first time that the M2-S31N channel blocker UAWJ280 has in vivo antiviral efficacy in mice that are infected with either oseltamivir sensitive or -resistant IAVs, and it has a synergistic antiviral effect with oseltamivir.


Subject(s)
Antibodies, Viral/blood , Antiviral Agents/pharmacology , Antiviral Agents/pharmacokinetics , Deuterium/chemistry , Drug Resistance, Viral , Influenza A virus/drug effects , Oseltamivir/pharmacology , Viral Matrix Proteins/antagonists & inhibitors , Viroporin Proteins/antagonists & inhibitors , Animals , Deuterium/pharmacokinetics , Deuterium/pharmacology , Dogs , Humans , Influenza A virus/classification , Madin Darby Canine Kidney Cells , Male , Mice, Inbred BALB C , Mutation , Orthomyxoviridae Infections/drug therapy , Orthomyxoviridae Infections/virology , Structure-Activity Relationship
8.
Bull Exp Biol Med ; 171(2): 262-264, 2021 May.
Article in English | MEDLINE | ID: mdl-34173112

ABSTRACT

We studied functional changes in rat pituitary-thyroid axis after a short-term shift in deuterium body content. Male Wistar rats consumed deuterium-enriched (500,000 ppm) or deuterium-depleted water (10 ppm) for 24 h. Rats of both experimental groups demonstrated elevated concentration of bound with transport proteins thyroxine and reduced level of thyroid-stimulating hormone in serum. No changes in the rate of thyroxine conversion to triiodothyronine were found. Thus, both the increase and reduction of deuterium body content produced similar changes in the function of the pituitary-thyroid axis with primary affection of the thyroid gland, indicative of its higher sensitivity to shift in deuterium levels.


Subject(s)
Deuterium/pharmacology , Fluid Shifts/drug effects , Pituitary Gland/drug effects , Thyroid Gland/drug effects , Animals , Body Fluids/chemistry , Body Fluids/drug effects , Body Fluids/metabolism , Body Weight/drug effects , Deuterium/metabolism , Fluid Shifts/physiology , Male , Organ Size/drug effects , Pituitary Gland/metabolism , Rats , Rats, Wistar , Thyroid Gland/metabolism , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood , Water-Electrolyte Balance/drug effects
9.
Cancer Control ; 28: 1073274821999655, 2021.
Article in English | MEDLINE | ID: mdl-33760674

ABSTRACT

The effects of deuterium-depleted water (DDW) containing deuterium (D) at a concentration of 25 parts per million (ppm), 50 ppm, 105 ppm and the control at 150 ppm were monitored in MIA-PaCa-2 pancreatic cancer cells by the real-time cell impedance detection xCELLigence method. The data revealed that lower deuterium concentrations corresponded to lower MiA PaCa-2 growth rate. Nuclear membrane turnover and nucleic acid synthesis rate at different D-concentrations were determined by targeted [1,2-13C2]-D-glucose fate associations. The data showed severely decreased oxidative pentose cycling, RNA ribose 13C labeling from [1,2-13C2]-D-glucose and nuclear membrane lignoceric (C24:0) acid turnover. Here, we treated advanced pancreatic cancer patients with DDW as an extra-mitochondrial deuterium-depleting strategy and evaluated overall patient survival. Eighty-six (36 male and 50 female) pancreatic adenocarcinoma patients were treated with conventional chemotherapy and natural water (control, 30 patients) or 85 ppm DDW (56 patients), which was gradually decreased to preparations with 65 ppm and 45 ppm deuterium content for each 1 to 3 months treatment period. Patient survival curves were calculated by the Kaplan-Meier method and Pearson correlation was taken between medial survival time (MST) and DDW treatment in pancreatic cancer patients. The MST for patients consuming DDW treatment (n = 56) was 19.6 months in comparison with the 6.36 months' MST achieved with chemotherapy alone (n = 30). There was a strong, statistically significant Pearson correlation (r = 0.504, p < 0.001) between survival time and length and frequency of DDW treatment.


Subject(s)
Deuterium/therapeutic use , Nuclear Envelope/drug effects , Pancreatic Neoplasms/genetics , RNA/drug effects , Cell Proliferation , Deuterium/pharmacology , Female , Humans , Male , Pancreatic Neoplasms
10.
Molecules ; 27(1)2021 Dec 31.
Article in English | MEDLINE | ID: mdl-35011474

ABSTRACT

The effect of a reduced deuterium (D) content in the incubation medium on the survival of cultured neurons in vitro and under glucose deprivation was studied. In addition, we studied the effect of a decrease in the deuterium content in the rat brain on oxidative processes in the nervous tissue, its antioxidant protection, and training of rats in the T-shaped maze test under hypoxic conditions. For experiments with cultures of neurons, 7-8-day cultures of cerebellar neurons were used. Determination of the rate of neuronal death in cultures was carried out using propidium iodide. Acute hypoxia with hypercapnia was simulated in rats by placing them in sealed vessels with a capacity of 1 L. The effect on oxidative processes in brain tissues was assessed by changes in the level of free radical oxidation and malondialdehyde. The effect on the antioxidant system of the brain was assessed by the activity of catalase. The study in the T-maze was carried out in accordance with the generally accepted methodology, the skill of alternating right-sided and left-sided loops on positive reinforcement was developed. This work has shown that a decrease in the deuterium content in the incubation medium to a level of -357‱ has a neuroprotective effect, increasing the survival rate of cultured neurons under glucose deprivation. When exposed to hypoxia, a preliminary decrease in the deuterium content in the rat brain to -261‱ prevents the development of oxidative stress in their nervous tissue and preserves the learning ability of animals in the T-shaped maze test at the level of the control group. A similar protective effect during the modification of the 2H/1H internal environment of the body by the consumption of DDW can potentially be used for the prevention of pathological conditions associated with the development of oxidative stress with damage to the central nervous system.


Subject(s)
Adaptation, Biological , Deuterium/metabolism , Glucose/metabolism , Hypoxia/metabolism , Neurons/metabolism , Animals , Antioxidants/metabolism , Antioxidants/physiology , Biomarkers , Cell Death , Cells, Cultured , Culture Media , Deuterium/pharmacology , Lipid Peroxidation , Neuroglia/metabolism , Neurons/drug effects , Oxidation-Reduction , Oxidative Stress , Rats
11.
Arch Biochem Biophys ; 692: 108532, 2020 10 15.
Article in English | MEDLINE | ID: mdl-32795451

ABSTRACT

Fatty acid uptake and accumulation in lipid droplets are essential processes of lipid metabolism. Oocyte in vitro culture in media enriched with fatty acid is used to modify the lipid content and composition, aiming to study the consequences of obesity and enhance cell cryotolerance. We applied Raman spectroscopy and deuterium labeling approach to quantify stearic acid uptake and investigate its incorporation within oocytes. Our data suggest that deuterium labeling does not affect oocyte maturation rates. The efficiency of deuterated stearic acid (dSA) uptake was shown to decrease with the increase of its concentration in culture medium and the duration of in vitro culture. The molar ratio between dSA and bovine serum albumin has no significant effect on the dSA uptake for 200 µM but modifies concentration dependence of the lipid uptake. dSA accumulates in all the lipid droplets inside oocytes. Different lipid droplets within the same oocyte exhibit different concentrations of dSA. The scatter in the dSA concentration in lipid droplets decreases with the culture time. Using dSA as an example, we provide a comprehensive description of how fatty acid concentration, its molar ratio versus bovine serum albumin, and culture time affect the uptake of the fatty acids in oocytes. Raman microspectroscopy of deuterium-labeled fatty acids is a nondestructive tool providing information about fatty acid uptake and heterogeneity of their accumulation between lipid droplets within the single oocyte.


Subject(s)
Deuterium , Lipid Droplets/metabolism , Oocytes/metabolism , Stearic Acids , Animals , Cats , Deuterium/chemistry , Deuterium/pharmacokinetics , Deuterium/pharmacology , Female , Isotope Labeling , Oocytes/cytology , Stearic Acids/chemistry , Stearic Acids/pharmacokinetics , Stearic Acids/pharmacology
12.
Sci Rep ; 10(1): 5217, 2020 03 23.
Article in English | MEDLINE | ID: mdl-32251307

ABSTRACT

In this study, we performed an adipogenic differentiation of human adipose-derived stem cells (ADSCs) in vitro with different deuterium content (natural, low and high) in the culture medium during differentiation process with parallel analysis of the gene expression, metabolic activity and cell viability/toxicity. After ADSCs differentiation into adipocytes we have done the analysis of differentiation process efficiency and determined a type of resulting adipocytes (by morphology, gene expression, UCP1 protein detection and adipokine production analysis). We have found that high (5 × 105 ppm) deuterium content significantly inhibit in vitro adipogenic differentiation of human ADSCs compared to the groups with natural (150 ppm) and low (30 ppm) deuterium content. Importantly, protocol of differentiation used in our study leads to white adipocytes development in groups with natural (control) and high deuterium content, whereas deuterium-depleted differentiation medium leads to brown-like (beige) adipocytes formation. We have also remarked the direct impact of deuterium on the cellular survival and metabolic activity. Interesting, in deuterium depleted-medium, the cells had normal survival rate and high metabolic activity, whereas the inhibitory effect of deuterated medium on ADSCs differentiation at least was partly associated with deuterium cytotoxicity and inhibitory effect on metabolic activity. The inhibitory effect of deuterium on metabolic activity and the subsequent decrease in the effectiveness of adipogenic differentiation is probably associated with mitochondrial dysfunction. Thus, deuterium could be considered as an element that affects the substance chirality. These findings may be the basis for the development of new approaches in the treatment of obesity, metabolic syndrome and diabetes through the regulation of adipose-derived stem cell differentiation and adipocyte functions.


Subject(s)
Adipocytes/drug effects , Adipogenesis/drug effects , Deuterium/pharmacology , Stem Cells/drug effects , Adipocytes/cytology , Adipokines/biosynthesis , Cells, Cultured , Chondrogenesis/drug effects , Culture Media/pharmacology , Gene Expression/drug effects , Humans , Osteogenesis/drug effects , Stem Cells/cytology , Subcutaneous Fat/cytology , Uncoupling Protein 1/biosynthesis , Uncoupling Protein 1/genetics
13.
J Med Chem ; 62(11): 5276-5297, 2019 06 13.
Article in English | MEDLINE | ID: mdl-30640460

ABSTRACT

The use of deuteration in medicinal chemistry has exploded in the past years, and the FDA has recently approved the first deuterium-labeled drug. Precision deuteration goes beyond the pure and simple amelioration of the pharmacokinetic parameters of a drug and might provide an opportunity when facing problems in terms of metabolism-mediated toxicity, drug interactions, and low bioactivation. The use of deuterium is even broader, offering the opportunity to lower the degree of epimerization, reduce the dose of coadministered boosters, and discover compounds where deuterium is the basis for the mechanism of action. Nevertheless, designing, synthesizing, and developing a successful deuterated drug is far from straightforward, and the translation from concept to practice is often unpredictable. This Perspective provides an overview of the recent developments of deuteration, with a focus on deuterated clinical candidates, and highlights both opportunities and challenges of this strategy.


Subject(s)
Deuterium/pharmacology , Animals , Chemistry, Pharmaceutical , Deuterium/chemistry , Deuterium/pharmacokinetics , Deuterium/toxicity , Humans
14.
ACS Chem Neurosci ; 10(1): 552-562, 2019 01 16.
Article in English | MEDLINE | ID: mdl-30343564

ABSTRACT

The mammalian olfactory receptors (ORs) constitute a large subfamily of the Class A G-protein coupled receptors (GPCRs). The molecular details of how these receptors convert odorant chemical information into neural signal are unknown, but are predicted by analogy to other GPCRs to involve stabilization of the activated form of the OR by the odorant. An alternative hypothesis maintains that the vibrational modes of an odorant's bonds constitute the main determinant for OR activation, and that odorants containing deuterium in place of hydrogen should activate different sets of OR family members. Experiments using heterologously expressed ORs have failed to show different responses for deuterated odorants, but experiments in the sensory neuron environment have been lacking. We tested the response to deuterated and nondeuterated versions of p-cymene, 1-octanol, 1-undecanol, and octanal in dissociated mouse olfactory receptor neurons (ORNs) by calcium imaging. In all, we tested 23 812 cells, including a subset expressing recombinant mouse olfactory receptor 2 ( Olfr2/OR-I7 ), and found that nearly all of the 1610 odorant-responding neurons were unable to distinguish the D- and H-odorants. These results support the conclusion that if mammals can perceive deuterated odorants differently, the difference arises from the receptor-independent steps of olfaction. Nevertheless, 0.81% of the responding ORNs responded differently to D- and H-odorants, and those in the octanal experiments responded selectively to H-octanal at concentrations from 3 to 100 µM. The few ORs responding differently to H and D may be hypersensitive to one of the several H/D physicochemical differences, such as the difference in H/D hydrophobicity.


Subject(s)
Calcium/metabolism , Deuterium/pharmacology , Olfactory Receptor Neurons/drug effects , Receptors, Odorant/metabolism , Aldehydes/pharmacology , Animals , Cymenes/pharmacology , Mice , Odorants , Olfactory Receptor Neurons/physiology , Receptors, G-Protein-Coupled/drug effects
15.
Mol Divers ; 23(2): 341-350, 2019 May.
Article in English | MEDLINE | ID: mdl-30238393

ABSTRACT

Deuterium substitution has been widely known that can improve the pharmacokinetic profiles due to isotope effect. Herein, a series of deuterated sorafenib derivatives have been synthesized and characterized by 1H NMR, 13C NMR and MS. Their antitumor activities were evaluated in vitro against human hepatoma cell line HepG2 and human cervical carcinoma cell line HeLa. The LogP values were detected by high-performance liquid chromatography. Subsequently, the metabolic stability and pharmacokinetics study were assessed in vitro and in vivo.


Subject(s)
Antineoplastic Agents , Deuterium , Sorafenib , Animals , Antineoplastic Agents/blood , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/pharmacology , Cell Survival/drug effects , Deuterium/chemistry , Deuterium/pharmacokinetics , Deuterium/pharmacology , HeLa Cells , Hep G2 Cells , Humans , Lipids/chemistry , Microsomes/metabolism , Rats, Wistar , Sorafenib/blood , Sorafenib/chemistry , Sorafenib/pharmacokinetics , Sorafenib/pharmacology
16.
J Biol Chem ; 294(7): 2279-2292, 2019 02 15.
Article in English | MEDLINE | ID: mdl-30545941

ABSTRACT

Substitution of protium (H) for deuterium (D) strongly affects biological systems. Whereas higher eukaryotes such as plants and mammals hardly survive a deuterium content of >30%, many microorganisms can grow on fully deuterated media, albeit at reduced rates. Very little is known about how the H/D replacement influences life at the systems level. Here, we used MS-based analysis to follow the adaptation of a large part of the Escherichia coli proteome from growth on a protonated full medium, over a protonated minimal medium, to a completely deuterated minimal medium. We could quantify >1800 proteins under all conditions, several 100 of which exhibited strong regulation during both adaptation processes. The adaptation to minimal medium strongly up-regulated amino acid synthesis and sugar metabolism and down-regulated translational proteins on average by 9%, concomitant with a reduction in growth rate from 1.8 to 0.67 h-1 In contrast, deuteration caused a very wide proteomic response over many cell functional categories, together with an additional down-regulation of the translational proteins by 5%. The latter coincided with a further reduction in growth rate to 0.37 h-1, revealing a clear linear correlation between growth rate and abundance of translational proteins. No significant morphological effects are observed under light and electron microscopies. Across all protein categories, about 80% of the proteins up-regulated under deuteration are enzymes with hydrogen transfer functions. Thus, the H/D kinetic isotope effect appears as the major limiting factor of cellular functions under deuteration.


Subject(s)
Cell Proliferation/drug effects , Deuterium/pharmacology , Escherichia coli Proteins/metabolism , Escherichia coli/metabolism , Proteome/metabolism , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Proteome/genetics
17.
ScientificWorldJournal ; 2018: 5454367, 2018.
Article in English | MEDLINE | ID: mdl-30519147

ABSTRACT

In current in vitro study we have shown the impact of deuterium content in growth medium on proliferation rate of human cultured adipose-derived stem cells (ADSC). ADSCs have also demonstrated morphological changes when cultured in deuterated growth medium: the cell cultures did not reach confluence but acquired polygonal morphology with pronounced stress fibers. At high deuterium concentrations the ADSCs population doubling time increased which indicated the cell cycle retardation and decrease of cell proliferation rate. The deuterated and deuterium-depleted growth media demonstrated acute and chronic cytotoxicity, respectively. The minimal migration ability was observed in deuterated medium whereas the highest migration activity was observed in the medium with the deuterium content close to natural. The cells in deuterated growth medium demonstrated decrease in metabolic activity after three days in culture. In contrast, in deuterium-depleted medium there was an increase in ADSC metabolic activity.


Subject(s)
Adipocytes/drug effects , Adipocytes/metabolism , Cell Differentiation/drug effects , Deuterium/pharmacology , Stem Cells/drug effects , Stem Cells/metabolism , Cell Differentiation/physiology , Cell Movement/drug effects , Cell Movement/physiology , Cell Proliferation/drug effects , Cell Proliferation/physiology , Cells, Cultured , Humans
18.
PLoS One ; 13(11): e0206279, 2018.
Article in English | MEDLINE | ID: mdl-30427871

ABSTRACT

Two chemotypes were examined in vitro with CYPs 3A4 and 2C19 by molecular docking, metabolic profiles, and intrinsic clearance deuterium isotope effects with specifically deuterated form to assess the potential for enhancement of pharmacokinetic parameters. The results show the complexity of deuteration as an approach for pharmacokinetic enhancement when CYP enzymes are involved in metabolic clearance. With CYP3A4 the rate limiting step was chemotype-dependent. With one chemotype no intrinsic clearance deuterium isotope effect was observed with any deuterated form, whereas with the other chemotype the rate limiting step was isotopically sensitive, and the magnitude of the intrinsic clearance isotope effect was dependent on the position(s) and extent of deuteration. Molecular docking and metabolic profiles aided in identifying sites for deuteration and predicted the possibility for metabolic switching. However, the potential for an isotope effect on the intrinsic clearance cannot be predicted and must be established by examining select deuterated versions of the chemotypes. The results show how in a deuteration strategy molecular docking, in-vitro metabolic profiles, and intrinsic clearance assessments with select deuterated versions of new chemical entities can be applied to determine the potential for pharmacokinetic enhancement in a discovery setting. They also help explain the substantial failures reported in the literature of deuterated versions of drugs to elicit a systemic enhancement on pharmacokinetic parameters.


Subject(s)
Cytochrome P-450 CYP2C19/chemistry , Cytochrome P-450 CYP3A/chemistry , Deuterium/chemistry , Pharmacokinetics , Cytochrome P-450 CYP2C19/radiation effects , Cytochrome P-450 CYP3A/radiation effects , Deuterium/pharmacology , Heme/chemistry , Heme/radiation effects , Humans , Inactivation, Metabolic , Kinetics , Microsomes/radiation effects , Molecular Docking Simulation , Oxidation-Reduction/radiation effects , Substrate Specificity
19.
FEBS J ; 285(16): 3002-3012, 2018 08.
Article in English | MEDLINE | ID: mdl-29933522

ABSTRACT

Huntington's disease (HD) is an autosomal dominant neurodegenerative disease which has no effective treatment and is characterized by psychiatric disorders, motor alterations, and dementia, with the cognitive deficits representing a devastating aspect of the disorder. Oxidative stress and elevated levels of lipid peroxidation (LPO) products are found in mouse models and patients with HD, suggesting that strategies to reduce LPO may be beneficial in HD. In contrast with traditional antioxidants, substituting hydrogen with deuterium at bis-allylic sites in polyunsaturated fatty acids (D-PUFA) decreases the rate-limiting initiation step of PUFA autoxidation, a strategy that has shown benefits in other neurodegenerative diseases. Here, we investigated the effect of D-PUFA treatment in a knock-in mouse model of HD (Q140) which presents motor deficits and neuropathology from a few months of age, and progressive cognitive decline. Q140 knock-in mice were fed a diet containing either D- or H-PUFAs for 5 months starting at 1 month of age. D-PUFA treatment significantly decreased F2 -isoprostanes in the striatum by approximately 80% as compared to H-PUFA treatment and improved performance in novel object recognition tests, without significantly changing motor deficits or huntingtin aggregation. Therefore, D-PUFA administration represents a promising new strategy to broadly reduce rates of LPO, and may be useful in improving a subset of the core deficits in HD.


Subject(s)
Cognitive Dysfunction/diet therapy , Deuterium/pharmacology , Huntington Disease/etiology , Linoleic Acid/pharmacology , Lipid Peroxidation/drug effects , Animals , Body Weight/drug effects , Cognitive Dysfunction/metabolism , Deuterium/chemistry , Dietary Supplements , Disease Models, Animal , Fatty Acids, Unsaturated/chemistry , Fatty Acids, Unsaturated/pharmacology , Female , Huntingtin Protein/genetics , Linoleic Acid/chemistry , Male , Mice, Transgenic , Motor Activity/drug effects
20.
J Anim Sci ; 96(8): 3330-3336, 2018 Jul 28.
Article in English | MEDLINE | ID: mdl-29800244

ABSTRACT

Vitamin E, as all-rac α-tocopheryl-acetate (TAc), has a bioavailability of only 5.4% in swine and, therefore, is a poor vitamin E source. Tocopheryl-phosphate (TP) has been used successfully as a vitamin E source around 1940 but it was subsequently replaced by TAc as it was easier to manufacture. Recently, it has been proposed as an in vivo intermediate in vitamin E metabolism with possibly gene-regulatory functions. TP may be more bioavailable than TAc as intestinal hydrolysis and emulsification are not required. The objective of this work was to compare the bioavailability of TAc and TP in swine. Piglets (18.6 ± 0.6 kg) fitted with jugular catheters received a single test meal (350 g) containing either deuterated (trimethyl-d9) TAc or TP (75 IU/kg body weight, n = 8 per treatment). Twelve serial blood samples were obtained starting premeal until 78 h postmeal for analysis of deuterated T and TP using LC MS/MS. Results were standardized by dividing them by the dose per kg body weight and were subsequently modeled with a multicompartment model. T from TAc had a slow appearance rate (0.040 ± 0.014 h-1) and rapid disappearance rate (0.438 ± 0.160 h-1) with a plateau value of 0.414 ± 0.129 µM/(µmol/kg BW). TP appeared faster in plasma (0.119 ± 0.058 h-1, P = 0.01) while the elimination rate was similar (0.396 ± 0.098 h-1, P = 0.51). The plateau value of TP was only numerically higher (0.758 ± 0.778 µM/(µmol/kg BW), P = 0.34). TP was quickly converted to T; its appearance rate was 0.026 ± 0.009 h-1, slower than the appearance rate of T from TAc (P = 0.01), whereas the elimination rate was 0.220 ± 0.062 h-1, slower than that of T from TAc (P = 0.00). The conversion of TP to T may have been incomplete, as its plateau value was only 0.315 ± 0.109 µM/(µmol/kg BW). The area under the curve, expressed relative to area under the curve for T from TAc, was 34.5% for TP and 107.3% for T from TP. These data confirm that TP is more quickly absorbed than T from TAc. TP is also converted to T and thus a functional precursor of T. Nevertheless, as a source of T, TP failed to offer a clear advantage over TAc in bioavailability.


Subject(s)
Acetates/pharmacology , Deuterium/pharmacology , Phosphates/pharmacology , Swine/physiology , Vitamin E/pharmacology , alpha-Tocopherol/analogs & derivatives , Animals , Biological Availability , Body Weight/drug effects , Tandem Mass Spectrometry/veterinary , Water , alpha-Tocopherol/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...